Vikki L. Conway, See "Remarks" at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 1,366 shares at $13.12 ($18K) on 2024-02-28, disclosed to the SEC on 2024-03-01.
Scheduled sale ($18k) by See "Remarks" under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TEVA | SELL | 2024-03-05 | $47K | — | Filing → |